Holdings (as at 2026-05-15)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Organon & Co. 3.88%
Humana Inc. 3.82%
Elevance Health Inc. 2.91%
DaVita Inc. 2.82%
Exelixis, Inc. 2.54%
Solventum Corporation 2.47%
Molina Healthcare, Inc. 2.41%
The Cigna Group 2.32%
Biogen Inc. 2.29%
Incyte Corporation 2.20%
Universal Health Services, Inc. (Class B) 2.04%
Cardinal Health, Inc. 2.01%
Zimmer Biomet Holdings, Inc. 2.01%
Chemed Corporation 1.99%
Regeneron Pharmaceuticals, Inc. 1.96%
HCA Healthcare, Inc. 1.94%
Bio-Rad Laboratories, Inc. (Class A) 1.93%
Globus Medical, Inc. (Class A) 1.93%
Encompass Health Corporation 1.91%
Tenet Healthcare Corporation 1.81%
Masimo Corporation 1.74%
Ionis Pharmaceuticals, Inc. 1.72%
Penumbra, Inc. 1.70%
United Therapeutics Corporation 1.67%
Merck & Co., Inc. 1.61%
Amgen Inc. 1.61%
Becton, Dickinson and Company 1.59%
Pfizer Inc. 1.57%
Illumina, Inc. 1.51%
QIAGEN N.V. 1.43%
Revvity, Inc. 1.40%
Henry Schein, Inc. 1.29%
UnitedHealth Group Incorporated 1.27%
Steris Plc 1.25%
Quest Diagnostics Incorporated 1.24%
Bristol-Myers Squibb Company 1.22%
Labcorp Holdings Inc. 1.22%
Gilead Sciences, Inc. 1.21%
Natera, Inc. 1.21%
ResMed Inc. 1.17%
Insmed Incorporated 1.16%
Medtronic Plc 1.14%
GE HealthCare Technologies Inc. 1.11%
The Cooper Companies, Inc. 1.09%
Sarepta Therapeutics, Inc. 1.05%
Neurocrine Biosciences, Inc. 1.04%
Certara, Inc. 1.02%
Waters Corporation 0.96%
Eli Lilly and Company 0.95%
Halozyme Therapeutics, Inc. 0.90%
IQVIA Holdings Inc. 0.86%
Agilent Technologies, Inc. 0.85%
Johnson & Johnson 0.80%
BioMarin Pharmaceutical Inc. 0.80%
Align Technology, Inc. 0.79%
Thermo Fisher Scientific Inc. 0.77%
Medpace Holdings, Inc. 0.76%
Abbott Laboratories 0.71%
Medline Inc. (Class A) 0.71%
Zoetis Inc. 0.55%
West Pharmaceutical Services, Inc. 0.49%
Royalty Pharma Plc (Class A) 0.45%
Sotera Health Company 0.43%
Edwards Lifesciences Corporation 0.41%
Vertex Pharmaceuticals Incorporated 0.40%
DexCom, Inc. 0.40%
AbbVie Inc. 0.40%
Stryker Corporation 0.38%
IDEXX Laboratories, Inc. 0.38%
Viking Therapeutics, Inc. 0.38%
Intuitive Surgical, Inc. 0.37%
Veeva Systems Inc. (Class A) 0.37%
Envista Holdings Corporation 0.37%
Danaher Corporation 0.35%
Alnylam Pharmaceuticals, Inc. 0.35%
Boston Scientific Corporation 0.34%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.